Related Experiment Videos
A novel model for equine recurrent airway obstruction
K S Bowles1, R E Beadle, S Mouch
1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Veterinary Immunology and Immunopathology
|June 20, 2002
Summary
A novel equine recurrent airway obstruction (RAO) model using ovalbumin-coated microbeads effectively mimics early disease stages. This research offers insights into the initial development of this common respiratory condition in horses.
Area of Science:
- Veterinary Medicine
- Equine Respiratory Diseases
- Immunology
Background:
- Equine recurrent airway obstruction (RAO) affects up to 50% of horses globally, with unknown causes.
- RAO pathogenesis may involve hypersensitivity to inhaled mold antigens, suggested by elevated IL-4 and IL-13 mRNA in affected horses.
- Early stages of RAO development in horses remain poorly understood.
Purpose of the Study:
- To develop and validate a novel airway model for studying early-stage equine recurrent airway obstruction (RAO).
- To investigate the initial inflammatory and immunological responses in horses following airway sensitization and challenge.
Main Methods:
- Development of a novel equine RAO model using ovalbumin-coated polystyrene microbeads for sensitization and challenge.
- Aerosolized ovalbumin-coated microbeads were administered to ponies.
- Assessment of airway mechanics, bronchoalveolar lavage fluid cytology, and Th2 cytokine responses.
Main Results:
- Aerosol challenge with ovalbumin-coated microbeads led to decreased airway compliance in ponies.
- Increased percentages of lymphocytes and neutrophils were observed in bronchoalveolar lavage fluid.
- Evidence of a Th2 cytokine response was detected in bronchoalveolar cells.
Conclusions:
- The novel microbead-based airway model successfully replicates key features of early equine RAO.
- This model provides a valuable tool for investigating the initial phases of RAO development in horses.
- Findings support the potential involvement of an atopic component in RAO pathogenesis.